Ch. Kindermann

No ORCID on file · 3 papers in corpus · active 1997-1999

Study types

  • article 3
article 1999
Clinical profile of Valette®
·doi:10.3109/13625189909085261

Studies have been undertaken to investigate the modulatory effects of a combination of 30 μg ethinylestradiol and 2.00 mg dienogest (Valette®) on ovarian function and on the hemostatic system. Modulation of ovarian function was investigated…

article 1997
Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 μg ethinyl estradiol and 2.00 mg dienogest on the hemostatic system
·doi:10.1016/s0010-7824(97)00094-2
article 1997
Modulation of ovarian function by an oral contraceptive containing 30 μg ethinyl estradiol in combination with 2.00 mg dienogest
·doi:10.1016/s0010-7824(97)00123-6